CTX-M-1-Related Extended-Spectrum Beta-Lactamases Producing Escherichia coli: so far a Sporadic Event in Western Austria

[1]  J. Rodríguez-Baño,et al.  Bacteremia Due to Extended-Spectrum β-Lactamase–Producing Escherichia coli in the CTX-M Era: A New Clinical Challenge , 2006 .

[2]  D. O’Callaghan,et al.  Virulence genotype and nematode-killing properties of extra-intestinal Escherichia coli producing CTX-M beta-lactamases. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[3]  R. Cantón,et al.  The CTX-M β-lactamase pandemic , 2006 .

[4]  J. Ariza,et al.  Risk-factors for acquisition of extended-spectrum beta-lactamase-producing Escherichia coli among hospitalised patients. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[5]  N. Woodford,et al.  Emergence of Enterobacteriaceae Isolates Producing CTX-M Extended-Spectrum β-Lactamase in Austria , 2006, Antimicrobial Agents and Chemotherapy.

[6]  D. Church,et al.  Virulence Factors of Escherichia coli Isolates That Produce CTX-M-Type Extended-Spectrum β-Lactamases , 2005, Antimicrobial Agents and Chemotherapy.

[7]  W. Bilker,et al.  Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection. , 2005, Archives of internal medicine.

[8]  G. Rossolini,et al.  Evolution of CTX-M-type beta-lactamases in isolates of Escherichia coli infecting hospital and community patients. , 2005, International journal of antimicrobial agents.

[9]  G. Jacoby,et al.  The new beta-lactamases. , 2005, The New England journal of medicine.

[10]  E. Denamur,et al.  Genetic Background of Escherichia coli and Extended-spectrum β-Lactamase Type , 2005, Emerging infectious diseases.

[11]  E. Gotuzzo,et al.  Detection of CTX-M-Type β-Lactamase Genes in Fecal Escherichia coli Isolates from Healthy Children in Bolivia and Peru , 2004, Antimicrobial Agents and Chemotherapy.

[12]  M. Kaufmann,et al.  Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. , 2004, The Journal of antimicrobial chemotherapy.

[13]  G. Barnaud,et al.  Dissemination of CTX-M-Type β-Lactamases among Clinical Isolates of Enterobacteriaceae in Paris, France , 2004, Antimicrobial Agents and Chemotherapy.

[14]  J. Rodríguez-Baño,et al.  Epidemiology and Clinical Features of Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Nonhospitalized Patients , 2004, Journal of Clinical Microbiology.

[15]  R. Bonnet.  Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes , 2004, Antimicrobial Agents and Chemotherapy.

[16]  M. Pimkin,et al.  Prevalence and Molecular Epidemiology of CTX-M Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Russian Hospitals , 2003, Antimicrobial Agents and Chemotherapy.

[17]  M. Kuskowski,et al.  Phylogenetic background and virulence profiles of fluoroquinolone-resistant clinical Escherichia coli isolates from the Netherlands. , 2002, The Journal of infectious diseases.

[18]  M. Gniadkowski.  Evolution and epidemiology of extended-spectrum beta-lactamases (ESBLs) and ESBL-producing microorganisms. , 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[19]  R. Cantón,et al.  Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  A. van Belkum,et al.  Application of Pulsed-Field Gel Electrophoresis and Binary Typing as Tools in Veterinary Clinical Microbiology and Molecular Epidemiologic Analysis of Bovine and HumanStaphylococcus aureus Isolates , 2000, Journal of Clinical Microbiology.

[21]  H. Goossens,et al.  Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  G. Jacoby,et al.  Quinolone resistance from a transferable plasmid , 1998, The Lancet.

[23]  Frederick E. Petry,et al.  Principles and Applications , 1997 .

[24]  F. Tenover,et al.  How to select and interpret molecular strain typing methods for epidemiological studies of bacterial infections: a review for healthcare epidemiologists. Molecular Typing Working Group of the Society for Healthcare Epidemiology of America. , 1997 .

[25]  F. Tenover,et al.  How to Select and Interpret Molecular Strain Typing Methods for Epidemiological Studies of Bacterial Infections A Review for Healthcare Epidemiologists , 1997, Infection Control & Hospital Epidemiology.

[26]  I. Stemplinger,et al.  Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 beta- lactamase: parallel outbreaks due to multiple plasmid transfer , 1996, Journal of clinical microbiology.

[27]  J. Rodríguez-Baño,et al.  Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  R. Cantón,et al.  The CTX-M beta-lactamase pandemic. , 2006, Current opinion in microbiology.

[29]  N. Woodford,et al.  Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases. , 2006, The Journal of antimicrobial chemotherapy.

[30]  G. Jacoby,et al.  The New b -Lactamases , 2005 .

[31]  M. Ferraro.  Performance standards for antimicrobial susceptibility testing , 2001 .

[32]  Ames,et al.  WIDESPREAD DISTRIBUTION OF URINARY TRACT INFECTIONS CAUSED BY A MULTIDRUG-RESISTANT ESCHERICHIA COLI CLONAL GROUP , 2001 .